Overview
The Cancer Research Institute is a nonprofit organization headquartered in New York City [1][7] that funds scientific research into cancer immunotherapy and supports collaboration among researchers to develop new cancer treatments [2]. Founded in 1953 [4], CRI has invested over $570 million into immunotherapy research [4][5]. The organization operates named grant programs including the Irvington Fellows program ($182M since 1970), the CRI Lloyd J. Old STARs Program ($46M since 2019), CLIP ($32.8M since 2012), Technology Impact Awards ($9.2M since 2017), Clinical Innovator Awards ($7.6M since 2023), and Immuno-Informatics Fellows ($4.9M since 2023) [6]. As of 2025, CRI reported $33 million in new funding across 68 new grants and fellowships at institutions in 15 US states and 5 countries, with 80 percent of funds directed to cancer research and patient programs [8].
The company's own site places it in New York: Cancer Research Institute is headquartered in New York City. The organization's website footer and official documentation list their address. [1]
CRI's impact page dates the organisation to 1953, stating it has invested over $570 million into immunotherapy research since 1953. [4]
CRI's named grant programs and their cumulative funding are the CRI Lloyd J. Old STARs Program ($46M since 2019), Irvington Fellows ($182M since 1970), Immuno-Informatics Fellows ($4.9M since 2023), CLIP ($32.8M since 2012), Technology Impact Awards ($9.2M since 2017) and Clinical Innovator Awards ($7.6M since 2023). [6]
The Cancer Research Institute's address is 29 Broadway, Floor 4, New York, NY 10006-3111. [7]
Growth & traction
CRI's homepage publishes $570M+ invested in research scientists worldwide, 30 cancers now treatable with immunotherapy, 9M+ patients benefiting from CRI research annually, and a July 2026 record of 94 awards totalling $37 million. [5]
CRI reported $33M in new funding in 2025 across 68 new grants and fellowships at 41 institutions in 15 US states and 5 countries, with 80% of funds directed to cancer research and patient programs and 20% to administration. [8]
Something wrong or missing? Send an update. Fixed within 24 hours.